Kuni Nakamura, Director at Gabelli Healthcare & WellnessRx Trust (GRX), bought 1,600 shares at $9.47 ($15K) on 2013-03-08, disclosed to the SEC on 2013-03-12.
Open-market purchase of $15k GRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ECF | BUY | 2019-07-12 | $19K | — | Filing → |
| GAB | BUY | 2018-05-30 | $25K | — | Filing → |
| GDV | BUY | 2018-05-30 | $25K | — | Filing → |